Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring.
Aged
Arrhythmias, Cardiac
/ diagnosis
COVID-19
/ epidemiology
Defibrillators, Implantable
Female
Follow-Up Studies
France
/ epidemiology
Heart Rate
Heart Ventricles
/ physiopathology
Humans
Incidence
Male
Middle Aged
Monitoring, Ambulatory
/ instrumentation
Prospective Studies
Quarantine
Remote Sensing Technology
/ instrumentation
SARS-CoV-2
Tachycardia, Ventricular
/ diagnosis
Arythmies ventriculaires
COVID-19 pandemic
Défibrillateur automatique implantable
Implantable cardioverter defibrillator: Remote monitoring
Télé-cardiologie
Ventricular arrhythmia
Épidémie du COVID-19
Journal
Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
20
01
2021
revised:
16
02
2021
accepted:
23
02
2021
pubmed:
6
6
2021
medline:
10
7
2021
entrez:
5
6
2021
Statut:
ppublish
Résumé
The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic. We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020. Five thousand nine hundred and fifty-four implantable cardioverter defibrillator recipients were followed by remote monitoring during the COVID-19 period (from 01 January to 31 May 2020). Data were obtained from automated remote follow-up of implantable cardioverter defibrillators utilizing the Implicity® platform. For all patients, the type of arrhythmia (atrial fibrillation, ventricular tachycardia or ventricular fibrillation), the number of ventricular arrhythmia episodes and the type of implantable cardioverter defibrillator-delivered therapy were recorded. A total of 472 (7.9%) patients presented 4917 ventricular arrhythmia events. An increase in ventricular arrhythmia incidence was observed after the first COVID-19 case in France, and especially during weeks #10 and #11, at the time of major governmental measures, with an increase in the incidence of antitachycardia pacing delivered therapy. During the 11 weeks before the lockdown order, the curve of the percentage of live-stream television coverage of COVID-19 information matched the ventricular arrhythmia incidence. During the lockdown, the incidence of ventricular arrhythmia decreased significantly compared with baseline (0.05±0.7 vs. 0.09±1.2 episodes per patient per week, respectively; P<0.001). Importantly, no correlation was observed between ventricular arrhythmia incidence and the curve of COVID-19 incidence. No changes were observed regarding atrial fibrillation/atrial tachycardia episodes over time. An increase in ventricular arrhythmia incidence was observed in the 2 weeks before the lockdown order, at the time of major governmental measures. Ventricular arrhythmia incidence decreased dramatically during the lockdown.
Sections du résumé
BACKGROUND
BACKGROUND
The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic.
AIMS
OBJECTIVE
We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020.
METHODS
METHODS
Five thousand nine hundred and fifty-four implantable cardioverter defibrillator recipients were followed by remote monitoring during the COVID-19 period (from 01 January to 31 May 2020). Data were obtained from automated remote follow-up of implantable cardioverter defibrillators utilizing the Implicity® platform. For all patients, the type of arrhythmia (atrial fibrillation, ventricular tachycardia or ventricular fibrillation), the number of ventricular arrhythmia episodes and the type of implantable cardioverter defibrillator-delivered therapy were recorded.
RESULTS
RESULTS
A total of 472 (7.9%) patients presented 4917 ventricular arrhythmia events. An increase in ventricular arrhythmia incidence was observed after the first COVID-19 case in France, and especially during weeks #10 and #11, at the time of major governmental measures, with an increase in the incidence of antitachycardia pacing delivered therapy. During the 11 weeks before the lockdown order, the curve of the percentage of live-stream television coverage of COVID-19 information matched the ventricular arrhythmia incidence. During the lockdown, the incidence of ventricular arrhythmia decreased significantly compared with baseline (0.05±0.7 vs. 0.09±1.2 episodes per patient per week, respectively; P<0.001). Importantly, no correlation was observed between ventricular arrhythmia incidence and the curve of COVID-19 incidence. No changes were observed regarding atrial fibrillation/atrial tachycardia episodes over time.
CONCLUSIONS
CONCLUSIONS
An increase in ventricular arrhythmia incidence was observed in the 2 weeks before the lockdown order, at the time of major governmental measures. Ventricular arrhythmia incidence decreased dramatically during the lockdown.
Identifiants
pubmed: 34088625
pii: S1875-2136(21)00089-9
doi: 10.1016/j.acvd.2021.02.005
pmc: PMC8141722
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
407-414Informations de copyright
Copyright © 2021 Elsevier Masson SAS. All rights reserved.
Références
Front Psychol. 2020 Jul 03;11:1713
pubmed: 32719646
Circ Res. 2014 Mar 14;114(6):1004-21
pubmed: 24625726
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
Rev Esp Cardiol. 2005 May;58(5):587-91
pubmed: 15899201
J Cardiopulm Rehabil Prev. 2020 Sep;40(5):285-286
pubmed: 32804796
JACC Clin Electrophysiol. 2021 Jan;7(1):6-11
pubmed: 33478713
Lancet Public Health. 2020 Aug;5(8):e437-e443
pubmed: 32473113
Int J Environ Res Public Health. 2020 Jul 28;17(15):
pubmed: 32731509
Eur Heart J. 2021 Feb 1;42(5):520-528
pubmed: 33321517
Transl Psychiatry. 2020 Aug 20;10(1):291
pubmed: 32820171
N Engl J Med. 1996 Feb 15;334(7):413-9
pubmed: 8552142
Eur Heart J. 2020 Jun 1;41(32):3045-3054
pubmed: 32562486
J Clin Med. 2020 Aug 19;9(9):
pubmed: 32825068
Indian Pacing Electrophysiol J. 2014 Oct 06;14(5):230-2
pubmed: 25408562